Familial Alzheimer's disease presenilin 1 mutation M146V increases gamma secretase cutting of p75NTR in vitro

Brain Research

Volumn 1147, Issue 1, 2007, Pages 248-255

  Hatchett, Caroline Sara ^a   Tyler, Sue ^a   Armstrong, Dawn ^a   Dawbarn, David ^a   Allen, Shelley Jane ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Secretase; Alzheimer's disease; Nerve growth factor; p75NTR; PC12; Presenilin

Indexed keywords

GAMMA SECRETASE; NEUROTROPHIN RECEPTOR; PRESENILIN 1; PROTEIN P75; PROTEIN TYROSINE KINASE A;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL STRAIN; CELL SURVIVAL; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; FAMILIAL DISEASE; GENE MUTATION; GENETIC TRANSFECTION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; STATISTICAL SIGNIFICANCE; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANALYSIS OF VARIANCE; ANIMALS; HYDROLYSIS; MUTATION; PC12 CELLS; PRESENILIN-1; RATS; RECEPTOR, NERVE GROWTH FACTOR;

EID: 34147181577     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.002     Document Type: Article

References (44)

1. Allen S.J., Dawbarn D., MacGowan S.H., Wilcock G.K., Treanor J.J.S., and Moss T.H. A Quantitative morphometric analysis of basal forebrain neurons expressing B-NGF receptors in normal and Alzheimer's disease brains. Dementia 1 (1990) 125-137
2. Allen S.J., Robertson A.G., Tyler S.J., Wilcock G.K., and Dawbarn D. Recombinant human nerve growth factor for clinical trials: protein expression, purification, stability and characterisation of binding to infusion pumps. J. Biochem. Biophys. Methods 47 (2001) 239-255
3. Ancolio K., Marambaud P., Dauch P., and Checler F. Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J. Neurochem. 69 (1997) 2494-2499
4. Bentahir M., Nyabi O., Verhamme J., Tolia A., Horre K., Wiltfang J., Esselmann H., and De Strooper B. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J. Neurochem. 96 (2006) 732-742
5. Berezovska O., Lleo A., Herl L.D., Frosch M.P., Stern E.A., Bacskai B.J., and Hyman B.T. Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J. Neurosci. 25 (2005) 3009-3017
6. Bibel M., Hoppe E., and Barde Y.A. Biochemical and functional interactions between the neurotrophin receptors Trk and p75NTR. EMBO J. 18 (1999) 616-622
7. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., and Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17 (1996) 1005-1013
8. Chao M.V. Dependence receptors: what is the mechanism?. Sci. STKE 2003 (2003) E38
9. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., and Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360 (1992) 672-674
10. Coulson E.J., Reid K., Baca M., Shipham K.A., Hulett S.M., Kilpatrick T.J., and Bartlett P.F. Chopper, a new death domain of the p75 neurotrophin receptor that mediates rapid neuronal cell death. J. Biol. Chem. 275 (2000) 30537-30545
11. Counts S.E., Nadeem M., Wuu J., Ginsberg S.D., Saragovi H.U., and Mufson E.J. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann. Neurol. 56 (2004) 520-531
12. Czech C., Tremp G., and Pradier L. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms. Prog. Neurobiol. 60 (2000) 363-384
13. DiStefano P.S., Chelsea D.M., Schick C.M., and McKelvy J.F. Involvement of a metalloprotease in low-affinity nerve growth factor receptor truncation: inhibition of truncation in vitro and in vivo. J. Neurosci. 13 (1993) 2405-2414
14. Ebinu J.O., and Yankner B.A. A RIP tide in neuronal signal transduction. Neuron 34 (2002) 499-502
15. Esler W.P., Kimberly W.T., Ostaszewski B.L., Diehl T.S., Moore C.L., Tsai J.Y., Rahmati T., Xia W., Selkoe D.J., and Wolfe M.S. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Nat. Cell Biol. 2 (2000) 428-434
16. Esposito D., Patel P., Stephens R.M., Perez P., Chao M.V., Kaplan D.R., and Hempstead B.L. The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J. Biol. Chem. 276 (2001) 32687-32695
17. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 2424-2428
18. Grob P.M., Ross A.H., Koprowski H., and Bothwell M. Characterization of the human melanoma nerve growth factor receptor. J. Biol. Chem. 260 (1985) 8044-8049
19. He X.L., and Garcia K.C. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 304 (2004) 870-875
20. Hempstead B.L., Martin-Zanca D., Kaplan D.R., Parada L.F., and Chao M.V. High-affinity NGF binding requires coexpression of the Trk proto-oncogene and the low-affinity NGF receptor. Nature 350 (1991) 678-683
21. Hock C., Heese K., Muller-Spahn F., Hulette C., Rosenberg C., and Otten U. Decreased TrkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci. Lett. 241 (1998) 151-154
22. Jung K.M., Tan S., Landman N., Petrova K., Murray S., Lewis R., Kim P.K., Kim D.S., Ryu S.H., Chao M.V., and Kim T.W. Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor. J. Biol. Chem. 278 (2003) 42161-42169
23. Kanning K.C., Hudson M., Amieux P.S., Wiley J.C., Bothwell M., and Schecterson L.C. Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J. Neurosci. 23 (2003) 5425-5436
24. Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S., and Selkoe D.J. Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6382-6387
25. Landman N., and Kim T.W. Got RIP? Presenilin-dependent intramembrane proteolysis in growth factor receptor signaling. Cytokine Growth Factor Rev. 15 (2004) 337-351
26. Lee K.F., Li E., Huber L.J., Landis S.C., Sharpe A.H., Chao M.V., and Jaenisch R. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69 (1992) 737-749
27. Li Y.M., Xu M., Lai M.T., Huang Q., Castro J.L., DiMuzio-Mower J., Harrison T., Lellis C., Nadin A., Neduvelil J.G., Register R.B., Sardana M.K., Shearman M.S., Smith A.L., Shi X.P., Yin K.C., Shafer J.A., and Gardell S.J. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405 (2000) 689-694
28. Mufson E.J., Ma S.Y., Cochran E.J., Bennett D.A., Beckett L.A., Jaffar S., Saragovi H.U., and Kordower J.H. Loss of nucleus basalis neurons containing TrkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 427 (2000) 19-30
29. Naumann T., Casademunt E., Hollerbach E., Hofmann J., Dechant G., Frotscher M., and Barde Y.A. Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J. Neurosci. 22 (2002) 2409-2418
30. Paul C.E., Vereker E., Dickson K.M., and Barker P.A. A pro-apoptotic fragment of the p75 neurotrophin receptor is expressed in p75NTRExonIV null mice. J. Neurosci. 24 (2004) 1917-1923
31. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., Russell W.E., Castner B.J., Johnson R.S., Fitzner J.N., Boyce R.W., Nelson N., Kozlosky C.J., Wolfson M.F., Rauch C.T., Cerretti D.P., Paxton R.J., March C.J., and Black R.A. An essential role for ectodomain shedding in mammalian development. Science 282 (1998) 1281-1284
32. Rabizadeh S., Ye X., Sperandio S., Wang J.J., Ellerby H.M., Ellerby L.M., Giza C., Andrusiak R.L., Frankowski H., Yaron Y., Moayeri N.N., Rovelli G., Evans C.J., Butcher L.L., Nolan G.P., Assa-Munt N., and Bredesen D.E. Neurotrophin dependence domain: a domain required for the mediation of apoptosis by the p75 neurotrophin receptor. J. Mol. Neurosci. 15 (2000) 215-229
33. Radeke M.J., Misko T.P., Hsu C., Herzenberg L.A., and Shooter E.M. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 325 (1987) 593-597
34. Ross A.H., Daou M.C., McKinnon C.A., Condon P.J., Lachyankar M.B., Stephens R.M., Kaplan D.R., and Wolf D.E. The neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkA. J. Cell Biol. 132 (1996) 945-953
35. Roux P.P., and Barker P.A. Neurotrophin signaling through the p75 neurotrophin receptor. Prog. Neurobiol. 67 (2002) 203-233
36. Sims N.R., Bowen D.M., Allen S.J., Smith C.C., Neary D., Thomas D.J., and Davison A.N. Presynaptic cholinergic dysfunction in patients with dementia. J. Neurochem. 40 (1983) 503-509
37. Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M., Takahashi Y., Thinakaran G., and Iwatsubo T. The role of presenilin cofactors in the gamma-secretase complex. Nature 422 (2003) 438-441
38. Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A.I., Gandy S.E., Jenkins N.A., Copeland N.G., Price D.L., and Sisodia S.S. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17 (1996) 181-190
39. Wang K.C., Kim J.A., Sivasankaran R., Segal R., and He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420 (2002) 74-78
40. Weskamp G., Schlondorff J., Lum L., Becherer J.D., Kim T.W., Saftig P., Hartmann D., Murphy G., and Blobel C.P. Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J. Biol. Chem. 279 (2004) 4241-4249
41. Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T., and Selkoe D.J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398 (1999) 513-517
42. Wong S.T., Henley J.R., Kanning K.C., Huang K.H., Bothwell M., and Poo M.M. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 5 (2002) 1302-1308
43. Yeo T.T., Chua-Couzens J., Butcher L.L., Bredesen D.E., Cooper J.D., Valletta J.S., Mobley W.C., and Longo F.M. Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J. Neurosci. 17 (1997) 7594-7605
44. Zampieri N., Xu C.F., Neubert T.A., and Chao M.V. Cleavage of p75 neurotrophin receptor by alpha-secretase and gamma-secretase requires specific receptor domains. J. Biol. Chem. 280 (2005) 14563-14571